Skip to main content
. 2022 May 4;2022:4269733. doi: 10.1155/2022/4269733

Figure 5.

Figure 5

(a) KRAS, TP53, and CDKN2A mutation statuses are dramatically related to a higher expression level of MBOAT2. (b) KRAS level was notably upregulated in the MBOAT2 high-expression group (P < 0.0001). (c–f) Linear relation analyses indicated that the MBOAT2 expression level is positively related to that of KRAS. P values were determined by nonparametric Mann-Whitney U-test in (a) and (b) (P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001).